Brought to you by 
Exact Sciences nets $51mm with IPO
22 Mar 2002
Executive Summary
Exact Sciences (formerly Exact Laboratories; cancer diagnostics) has netted $51mm with an initial public offering of 4mm common shares priced at $14 each---3.2mm will trade on Nasdaq, the remaining 800k will trade on international markets.
Deal Industry
- Biotechnology
- In Vitro Diagnostics
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Exact Sciences nets $51mm with IPO
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice